GAPf | New HIV Drugs v2

May 24, 2023

GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes

The GAP-f pDTG task team has developed a brief outlining product introduction and rollout considerations for national programmes when...

May 24, 2022

GAP-f pDTG Implementation Considerations for National Programmes

In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 ...

HIV New Product Introduction Toolkit